Commercial Responsibilities. Licensee agrees to use commercially reasonable efforts to Commercialize Licensed Products and to cause the commercial launch of Licensed Products in the Major Market Countries within six (6) months of Regulatory Approval in such Major Market Countries. In making any determination regarding such commercially reasonable efforts, the Parties shall take into account the normal course of such programs conducted with sound and reasonable business practices and judgment.
Commercial Responsibilities. TMC agrees to use commercially reasonable efforts to Commercialize Products, which efforts are consistent with the efforts and resources that TMC or a United States-based, mid-sized, specialty pharmaceutical company devotes to products of similar market potential and in similar product lifecycle positions based on conditions then prevailing with respect to the applicable product and the relevant markets. If TMC does not fulfill its commercial diligence obligations set forth in this Article 3, ALZA will be entitled, but not obligated, to terminate the License and this Agreement, subject to the terms of Section 15.4 below. CONFIDENTIAL MATERIALS OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. DOUBLE ASTERISKS [**] DENOTE OMISSIONS.
Commercial Responsibilities. Centocor agrees to use commercially reasonable efforts consistent with its and its pharmaceutical Affiliates' normal business practices, and in no event less than efforts standard in the pharmaceutical industry, to Commercialize Licensed Products. Such efforts shall be consistent with efforts used by Centocor (in each case comparable to such efforts used by Centocor's principal pharmaceutical marketing Affiliate responsible for marketing in the country where the Commercialization takes place for that Licensed Product) in Commercializing its own Products that are similar with regard to, for example, market potential, price per treatment, patient population and competitive position. Centocor shall use commercially reasonable efforts to effect the commercial launch of Licensed Products in the Major Market Countries within six (6) months of Regulatory Approval in such Major Market Countries.
Commercial Responsibilities. Subject to the terms and conditions of this Agreement, including this Section 4.6 and ARTICLE V, Licensee will have sole responsibility for, authority over, and discretion with respect to, at its own expense, the Commercialization of the Licensed Products in the Field in the Territory. Licensee will be responsible for the day-to-day implementation of any such Commercialization activities.
Commercial Responsibilities. Pulmatrix agrees to use Commercially Reasonable Efforts to Commercialize Licensed Products and to cause the commercial launch of Licensed Products in the US and at least one EU country within six (6) months of Regulatory Approval in each of the US or EU, respectively.
Commercial Responsibilities. Xxxxxxx agrees to use commercially reasonable efforts consistent with its normal business practices, and in no event less than efforts standard in the pharmaceutical industry, to develop and commercialize Licensed Products. Such efforts shall be efforts consistent with efforts used by Xxxxxxx (in each case comparable efforts will be measured against such efforts used by Xxxxxxx for marketing in the country where the commercialization takes place for that Licensed Product) in commercializing its own products that are similar with regard to, for example, market potential, price per treatment, patient population, and competitive position. Xxxxxxx shall use commercially reasonable efforts consistent with its normal business practices to effect the commercial launch of Licensed Products in the Major Countries within [* *] of Regulatory Approval in such Major Countries.
